Skip to main
TDOC
TDOC logo

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 36 analyst ratings
Hold
Strong Buy 17%
Buy 25%
Hold 56%
Sell 0%
Strong Sell 3%

Bulls say

Teladoc Health has demonstrated promising signs of recovery with sequential membership growth in its BetterHelp segment and the onboarding of 800 new clients in Integrated Care, indicating a revitalization in its customer base. Additionally, the Chronic Care program has seen an increase in enrollment, reaching approximately 1.203 million, which reflects a year-over-year growth of 4%, highlighting the increasing utilization of Teladoc’s services. Furthermore, the company’s ability to manage expenses has resulted in a fourth-quarter GAAP EPS loss that was significantly better than anticipated, bolstering the overall outlook for growth in a market poised for expansion.

Bears say

Teladoc Health has experienced a 3.0% year-over-year decline in total revenue, primarily attributed to a 9.5% decrease in the BetterHelp segment, which accounted for a significant portion of its overall earnings. The company's Integrated Care segment showed modest growth of 1.6%, but this was insufficient to offset the contraction in BetterHelp, raising concerns about overall profitability and growth prospects. Additionally, a continuous decline in BetterHelp users for five consecutive quarters and management's cautious profit outlook, influenced by challenges stemming from the Catapult acquisition, further contributes to a negative financial outlook for Teladoc Health.

Teladoc (TDOC) has been analyzed by 36 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 25% recommend Buy, 56% suggest Holding, 0% advise Selling, and 3% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 36 analysts, Teladoc (TDOC) has a Hold consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $42.63, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $42.63, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.